Thu.Nov 07, 2024

article thumbnail

Healthcare Email Marketing Strategies: A Guide for Pharma Executives

Pharma Marketing Network

In today’s digital world, healthcare email marketing is more than just sending out newsletters. It’s a strategic tool that, when done right, can boost engagement, nurture relationships with healthcare professionals (HCPs), and increase brand awareness. But how can pharma companies truly maximize the potential of email marketing? Let’s dive in and explore some proven strategies.

article thumbnail

Buspirone alternatives: What can I take instead of buspirone?

The Checkup by Singlecare

Buspirone (formerly available under the brand name Buspar ) is a generic prescription medication used to help manage generalized anxiety disorder (GAD) and treat symptoms of anxiety. Buspirone may also be used off-label for major depressive disorder. As an anxiolytic drug, buspirone is believed to lower anxiety by regulating serotonin and dopamine receptors in the brain.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Master Pharmacy Cash Flow with These 3 KPIs

DiversifyRx

The pharmacy cash flow crisis for independent pharmacy owners is NOT over! Master these 3 KPIs and dramatically improve your cash flow before the end of the year. The so-called DIR Fee Apocalypse may be over, but don’t let that give you a false sense of security. For many independent pharmacy owners, pharmacy cash flow remains THE #1 PROBLEM. It’s pushing some owners to close their doors or drown in debt.

article thumbnail

Is nausea a symptom of diabetes?

The Checkup by Singlecare

Diabetes mellitus is a chronic condition that causes high blood sugar levels. As the body struggles to control elevated blood glucose, you may experience increased thirst, frequent urination, and fatigue. Vision changes, dehydration, and slow-healing sores can also occur. Although it’s not a direct cause of diabetes, nausea can occur due to blood sugar fluctuations and other diabetes complications.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Single-use bioreactor market to witness favourable expansion to 2030

European Pharmaceutical Review

A report by Azoth Analytics expects that globally, the single-use technology rocking bioreactors market will grow at a compound annual growth rate (CAGR) of 3.9 percent between 2025 and 2030. With the industry transitioning to single-use technologies in bioprocessing, the single-use technology rocking bioreactors market is gaining traction, according to the report.

article thumbnail

Is prednisone good for migraines?

The Checkup by Singlecare

Prednisone (and dexamethasone ) are corticosteroids that treat conditions such as allergies, inflammation, asthma, and much more. They’re prescription drugs that work by reducing swelling and symptoms caused by immune system reactions. Since inflammation can also contribute to episodic migraines , and the treatment of acute migraines often entails anti-inflammatory drugs, could prednisone be used to treat cephalgia (or head pain ), too?

More Trending

article thumbnail

Gastrointestinal Stromal Tumors Increased in Past 20 Years

Drug Topics

Researchers attempted to understand the evolving epidemiology of gastrointestinal stromal tumors in major organ sites.

article thumbnail

Among 2024’s modest M&A action, cancer, immunology and neuroscience deals trickle in

PharmaVoice

Dealmaking this year has been largely muted, but M&A trends are pointing to the areas where pharma is placing the most emphasis.

article thumbnail

Q&A: Pharmacists Champion Nonopioid Pain Management Strategies

Drug Topics

Melissa Durham, PharmD, MACM, reveals how pharmacists are uniquely positioned to counsel patients on nonopioid pain management.

article thumbnail

GLP-1s Are At the Forefront, but Other Obesity Treatments Exist

Pharmacy Times

In addition to GLP-1s, dual GLP-1 and GIP agonists, intestinal lipase inhibitors, sympathomimetics, and other agents can help patients lose weight.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Q&A: Key Things Pharmacists Need to Know About Insulin Icodec

Drug Topics

Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, discusses a recent meta-analysis that evaluated the efficacy, safety, and clinical implications of insulin icodec.

article thumbnail

Implementation of Supply-Related Restrictive Measures Reduces IVIG Use

Pharmacy Times

Efforts include a mandatory intravenous immunoglobulin ordering form, blood bank gatekeeping, and a stewardship committee to ensure optimized use.

article thumbnail

These 6 companies are using AI to streamline clinical trials for pharma

STAT

In the last year, drugmakers have talked up the prospect of medicines discovered or designed by artificial intelligence.

article thumbnail

Risk of Developing Eosinophilic Esophagitis Is Higher in Pediatric Patients With Atopic Conditions

Pharmacy Times

Children with certain atopic conditions, including asthma and common food allergies, were observed to have a higher risk of developing the chronic disorder.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

An RNAi renaissance is creating a new generation of startups

PharmaVoice

Pioneers like Alnylam Pharmaceuticals have led the RNA interference field for years. Now, a crop of young biotechs is building on that foundation by taking the drugmaking technology in new directions.

article thumbnail

Preventive Biologics May Aid the Antibiotic Resistance Crisis

Pharmacy Times

New technology and innovation may help turn the corner on antibiotic resistance.

article thumbnail

Quest Diagnostics expands network partnership with Anthem plans

Fierce Healthcare

Quest Diagnostics and Elevance Health are broadening their partnership into four more states with the goal of making it easier for patients to access in-network laboratory services. | Quest Diagnostics and Elevance Health are broadening their partnership into four more states, with the goal of making it easier for patients to access in-network laboratory services.

article thumbnail

FDA Proposes Removal of OTC Oral Phenylephrine From Cough/Cold Products

Pharmacy Times

Evidence shows that the agent is not an effective nasal decongestant.

FDA
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

General Catalyst's HATCo moves forward on $485M Summa Health deal

Fierce Healthcare

Venture capital firm General Catalyst's Health Assurance Transformation Corporation (HATCo) signed a definitive agreement to buy Summa Health for $485 million, the organizations announced Thursday. | Venture capital firm General Catalyst's Health Assurance Transformation Corporation signed a definitive agreement to buy Summa Health for $485 million, the organizations announced Thursday.

article thumbnail

Sarepta pulls plug on Duchenne exon-skipping drug

pharmaphorum

Sarepta has halted development of vesleteplirsen, a follow-up to its Duchenne muscular dystrophy therapy Exondys 51.

article thumbnail

Oscar Health racks up $55M net loss as all eyes turn to ACA enhanced subsidies

Fierce Healthcare

Oscar Health CEO Mark Bertolini’s implied message to Republicans eager to let the Affordable Care Act’s (ACA's) enhanced subsidies expire was clear: Do so at your own risk. | Unwaveringly, Oscar CEO Mark Bertolini expects the ACA subsidies to be extended one way or another. The company raised its full-year guidance during the third quarter earning's call.

article thumbnail

More turbulence at Aurinia as autoimmune drugmaker lays off 45% of workforce

Fierce Pharma

After an activist investor revolted against the leadership team at Aurinia Pharmaceuticals, the CEO in question is resorting to restructuring. | After an activist investor revolted against the leadership team at Aurinia Pharmaceuticals, the CEO in question is resorting to restructuring, cutting the autoimmune disease biotech's workforce for a second time in less than a year.

article thumbnail

Webinar recap: Boosting recruitment and retention with SDOH data

pharmaphorum

Discover the key takeaways from a webinar focused on boosting recruitment and retention through Social Determinants of Health (SDOH) data. Learn how incorporating SDOH data can enhance your recruitment and retention strategies.

article thumbnail

Gilead's CAR-T sales stagnate as Trodelvy takes another impairment hit

Fierce Pharma

Despite a mission to become a dominant cancer drug player, Gilead Sciences has as of late been locked in on its bread-and-butter antirival franchise with an eye on the potential of its long-acting | Gilead's CAR-T therapies Yescarta and Tecartus have stayed relatively flat all year with its Yescarta facing a 1% decline over the third quarter due to competition.

article thumbnail

Avid Bioservices to go private in $1.1bn private equity deal

pharmaphorum

Nasdaq-listed CDMO Avid Bioservices has agreed a $1.

article thumbnail

Lerodalcibep Delivers Significant LDL-C Reduction for High-Risk Cardiovascular Patients

Pharmacy Times

Lerodalcibep is a novel, third-generation, anti-PCSK9 therapy small binding protein.

article thumbnail

Blueprint's mastocytosis drug Ayvakit cleared for NHS use

pharmaphorum

NICE has recommended broad use of Blueprint Medicines' recently-approved therapy for rare blood disorder advanced systemic mastocytosis

article thumbnail

EMA approves Sanofi/Regeneron’s Dupixent for young EoE patients

Pharmaceutical Technology

The EMA has granted approval for Sanofi/Regeneron’s Dupixent (dupilumab) to treat EoE in children as young as one.

article thumbnail

Novo Nordisk signs $285 million deal for a once-monthly GLP-1 receptor agonist

Outsourcing Pharma

Wegovy manufacturer Ascendis Pharma has been tasked with supporting the development of a once-monthly GLP-1 drug.

article thumbnail

Sparked by FDA expansion, Sarepta's Elevidys takes another leap in sales

Fierce Pharma

An FDA expansion of Sarepta Therapeutics’ Duchenne muscular dystrophy (DMD) Elevidys has sparked a new surge in sales for the gene therapy. | An FDA expansion of Sarepta Therapeutics’ Duchenne muscular dystrophy Elevidys has sparked a new surge in sales. The gene therapy's $181 million sales in the third quarter beat analysts' expectations as it made a 48% sequential leap.

FDA
article thumbnail

Minister for Science champions partnerships with private clinical sector in UK

Pharmaceutical Technology

Lord Vallance stated the government sees investment, innovation, and public-private partnership as crucial to UK healthcare.

article thumbnail

Aditum Bio and Leads Biolabs Form New Company, Oblenio Bio, for Developing a Therapeutic Antibody to Treat Autoimmune Disorders

BioPharm

Under an agreement, Leads Biolabs has granted the new company, Oblenio Bio, an exclusive option to license LBL-051, a tri-specific T-cell engager antibody.

article thumbnail

DBV Technologies’ stock slides as financial woes worsens

Pharmaceutical Technology

The company reported that it does not have sufficient cash reserves to operate for the next 12 months, can only fund operations into Q1 2025.